Death-Associated Protein Kinase 3 (DAPK3) (Internal Region) Peptide

Details for Product No. ABIN1382007
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Protein Name
Synonyms DAPK3, dapk3, wu:fc25b08, si:dkey-57k2.5, MGC114871, ZIP, ZIPK, dlk, Dapkl
Protein Region
Internal Region
Origin
Human
(1)
Application
Blocking Peptide (BP)
Pubmed 3 references available
Quantity 0.05 mg
Shipping to United States ( )
Availability Will be delivered in 2 to 3 Business Days
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Characteristics 20 amino acids near the center of human ZIPK.
Human
Alternative Name ZIPK
Application Notes ZIPK peptide is used for blocking the activity of ZIPK.
Restrictions For Research Use only
Format Liquid
Concentration 200 μg/mL
Buffer PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage -20 °C
Expiry Date 12 months
Background publications Kawai, Matsumoto, Takeda et al.: "ZIP kinase, a novel serine/threonine kinase which mediates apoptosis." in: Molecular and cellular biology, Vol. 18, Issue 3, pp. 1642-51, 1998 (PubMed).

Woronicz, Gao, Cao et al.: "IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK." in: Science (New York, N.Y.), Vol. 278, Issue 5339, pp. 866-9, 1997 (PubMed).

Zandi, Rothwarf, Delhase et al.: "The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation." in: Cell, Vol. 91, Issue 2, pp. 243-52, 1997 (PubMed).

Validation Images
Catalog No. ABIN1382007
93.50 $
Plus shipping costs $45.00
Quantity
Price
0.05 mg
93.50 $

Order hotline:

  • +1 404 474 4654
  • +1 888 205 9894 (TF)